Patentability Of Frontline Plus Formulation Claims Confirmed



Published:

Merial announced today the United States Patent and Trademark Office reconfirmed the patentability of formulation claims covering Merial’s Frontline Plus, a flea and tick control product.

“The ultimate result is that we expect some of the products infringing the formulation claims to be removed from the market.” says Judy Jarecki-Black, PhD, Esq., head of intellectual property with Merial, an animal health pharmaceutical company.

Additional information regarding companies involved with potential formulation infringement and actionable steps was expected to be released later this week, according to earlier information from a public relations representative. The release of the additional information is now expeted in coming weeks, according to Merial.

“We are pleased that the patent office confirmed the patentability of Merial’s inventions directed at fipronil and (S)-methoprene containing spot-on compositions,” Dr. Jarecki-Black says. “Merial is also pursuing litigation against other manufacturers in cases where it believes its patents have been violated. We plan to continue to vigorously defend our patent rights and continue our strong support of the veterinary profession.”

<Home>

Archive »Read More

Too Many Veterinarians, or a Bubble Market?

How can a scientifically trained profession keep ignoring the facts of too many graduates chasing too few jobs with an ever increasing debt burden?

Former Head of ASPCA Takes Over at PIJAC

The pet industry reacts over the controversial decision to hire former ASPCA executive Edwin J. Sayres as president and CEO of the Pet Industry Joint Advisory Council.

K-State Offers New Course on Regulation of Animal Drugs, Vaccines

The course begins this fall and is available through distance learning or on the K-State Olathe campus.

Add your comment:

Events


Show More...